Cargando…

Virtual Screening in Lead Discovery: A Viewpoint†

Virtual screening (VS) methods have emerged as an adaptive response to massive throughput synthesis and screening technologies. Based on the structure-permeability paradigm, the Lipinski rule of five has become a standard property filtering protocol for VS. Three possible VS scenarios with respect t...

Descripción completa

Detalles Bibliográficos
Autor principal: Oprea, Tudor Ionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146595/
http://dx.doi.org/10.3390/70100051
_version_ 1783356427844190208
author Oprea, Tudor Ionel
author_facet Oprea, Tudor Ionel
author_sort Oprea, Tudor Ionel
collection PubMed
description Virtual screening (VS) methods have emerged as an adaptive response to massive throughput synthesis and screening technologies. Based on the structure-permeability paradigm, the Lipinski rule of five has become a standard property filtering protocol for VS. Three possible VS scenarios with respect to optimising binding affinity and pharmacokinetic properties are discussed. The parsimony principle for selecting candidate leads for further optimisation is advocated.
format Online
Article
Text
id pubmed-6146595
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61465952018-11-19 Virtual Screening in Lead Discovery: A Viewpoint† Oprea, Tudor Ionel Molecules Article Virtual screening (VS) methods have emerged as an adaptive response to massive throughput synthesis and screening technologies. Based on the structure-permeability paradigm, the Lipinski rule of five has become a standard property filtering protocol for VS. Three possible VS scenarios with respect to optimising binding affinity and pharmacokinetic properties are discussed. The parsimony principle for selecting candidate leads for further optimisation is advocated. MDPI 2002-01-31 /pmc/articles/PMC6146595/ http://dx.doi.org/10.3390/70100051 Text en © 2002 by Tudor Ionel Oprea (tudor.oprea@astrazeneca.com). Reproduction is permitted for non commercial purposes
spellingShingle Article
Oprea, Tudor Ionel
Virtual Screening in Lead Discovery: A Viewpoint†
title Virtual Screening in Lead Discovery: A Viewpoint†
title_full Virtual Screening in Lead Discovery: A Viewpoint†
title_fullStr Virtual Screening in Lead Discovery: A Viewpoint†
title_full_unstemmed Virtual Screening in Lead Discovery: A Viewpoint†
title_short Virtual Screening in Lead Discovery: A Viewpoint†
title_sort virtual screening in lead discovery: a viewpoint†
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146595/
http://dx.doi.org/10.3390/70100051
work_keys_str_mv AT opreatudorionel virtualscreeninginleaddiscoveryaviewpoint